DCC (DCC) Given Buy Rating at UBS Group

Share on StockTwits

UBS Group reissued their buy rating on shares of DCC (LON:DCC) in a research note published on Friday morning, ThisIsMoney.Co.Uk reports.

Several other brokerages have also commented on DCC. Canaccord Genuity reiterated a buy rating and set a GBX 8,540 ($111.59) price objective on shares of DCC in a report on Tuesday, February 5th. Goldman Sachs Group lowered DCC to a neutral rating and decreased their price objective for the company from GBX 8,500 ($111.07) to GBX 7,900 ($103.23) in a report on Monday, January 21st. Finally, Peel Hunt reiterated an add rating and set a GBX 7,108 ($92.88) price objective on shares of DCC in a report on Tuesday, February 5th. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company presently has an average rating of Buy and a consensus price target of GBX 8,374.22 ($109.42).

Shares of DCC traded down GBX 8 ($0.10) during midday trading on Friday, hitting GBX 6,590 ($86.11). 119,655 shares of the company’s stock traded hands, compared to its average volume of 258,121. DCC has a 1 year low of GBX 5,555 ($72.59) and a 1 year high of GBX 7,585 ($99.11). The company has a current ratio of 1.21, a quick ratio of 0.91 and a debt-to-equity ratio of 115.45. The firm has a market cap of $6.48 billion and a PE ratio of 24.44.

About DCC

DCC plc provides sales, marketing, and support services worldwide. The company's DCC LPG segment sells and markets liquefied petroleum gas (LPG). This segment serves approximately 0.7 million customers. Its DCC Retail & Oil segment engages in the procurement, sale, marketing, and distribution of LPG; operation of retail petrol stations; and reselling of fuel cards.

Featured Article: What are the qualifications of a portfolio manager?

Analyst Recommendations for DCC (LON:DCC)

Receive News & Ratings for DCC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DCC and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

HC Wainwright Analysts Give Armata Pharmaceuticals  a $7.00 Price Target
HC Wainwright Analysts Give Armata Pharmaceuticals a $7.00 Price Target
Heroux Devtek  Issues Quarterly  Earnings Results
Heroux Devtek Issues Quarterly Earnings Results
Stock Traders Buy High Volume of Call Options on Northern Trust
Stock Traders Buy High Volume of Call Options on Northern Trust
Head-To-Head Comparison: Helix Energy Solutions Group  and Gazprom Neft’ PAO
Head-To-Head Comparison: Helix Energy Solutions Group and Gazprom Neft’ PAO
Thermo Fisher Scientific  Price Target Increased to $320.00 by Analysts at UBS Group
Thermo Fisher Scientific Price Target Increased to $320.00 by Analysts at UBS Group
GLENCORE PLC/ADR  Hits New 12-Month Low at $6.71
GLENCORE PLC/ADR Hits New 12-Month Low at $6.71


 
© 2006-2019 Zolmax.